Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PAREXEL International Corporation, a global biopharmaceutical services provider has announced the launch of its patient sensor solution, a new offering that securely captures, transmits, stores, and visualizes study subject data in clinical trials.
read more
PAREXEL International Corporation has launched the next generation of its Perceptive MyTrials® platform with advanced analytics capabilities.
read more
Tuesday, December 01, 2015
IMPACT Express provides a quick-to-implement, cost-effective clinical trial management solution to simplify clinical trial management and monitoring for small to mid-sized biopharmaceutical companies.
read more
Monday, November 14, 2016
PAREXEL International Corporation a global biopharmaceutical services provider, has launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies. LIQUENT InSight® for IDMP™ is the newest module added to ...
read more
Parexel announced the expansion of its capabilities through a new Hong Kong presence established by its healthcare consulting Health Advances subsidiary.
read more
Thursday, February 18, 2016
PAREXEL International Corporation, a global biopharmaceutical services organization, today has announced expanded services and capabilities in genomic-based drug development.
read more
Monday, February 13, 2017
PAREXEL International Corporation, a global biopharmaceutical services provider, has launched a mobile app for the ClinPhone® RTSM (randomization and trial supply management) service. The app is designed to enhance clinical trial supply management ...
read more
PAREXEL International Corporation has announced the launch of its Active Tracking service. The service follows Good Distribution Practice (GDP) requirements by providing biopharmaceutical companies with near real-time temperature and location ...
read more
Wednesday, September 12, 2018
PAREXEL announced the launch of its Patient Innovation Center, designed to help guide sponsors in their efforts to improve efficiency and success across all areas of biopharmaceutical development including clinical trial design, recruitment, ...
read more
Wednesday, January 09, 2019
PAREXEL has introduced a new, dedicated division to support emerging biotech companies in reaching their drug development and commercialization goals quickly and cost-effectively.
read more
PAREXEL International Corporation (Nasdaq: PRXL)(“PAREXEL” or the “Company”), a global clinical research organization, announced today that the Company has acquired all of the outstanding equity securities of ATLAS Medical Services (“ATLAS”), a ...
read more
Thursday, December 27, 2012
PAREXEL International Corporation announced today that on December 21, 2012, the Company acquired all of the outstanding equity securities of Liquent, Inc., a leading global provider of Regulatory Information Management (RIM) solutions. Liquent ...
read more
Friday, February 04, 2022
Medidata, a Dassault Systèmes company, announced that Parexel is extending their 15-year global strategic partnership. This builds upon the trusted relationship between the two companies and sets the goal of jointly pioneering a new era of ...
read more
Experts from PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, will address topics including observational data methods, commercialization, and coverage policy during the International Society for...
read more
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in ...
read more